Catheter-based epicardial closure of the left atrial appendage

Interventional Cardiology Clinics

Volumn 3, Issue 2, 2014, Pages 219-227

  Santoro, Francesco ^a   Di Biase, Luigi ^a,b,c,d   Santangeli, Pasquale ^a,b   Bai, Rong ^b   Danik, Stephan ^e   Barrett, Conor ^e   Horton, Rodney ^b   Burkhardt, J David ^b   Natale, Andrea ^b,d,f,g,h,i  

^a UNIVERSITY OF FOGGIA   (Italy)

^b TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d The University of Texas at Austin   (United States)

^e ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^f CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ SCRIPPS CLINIC   (United States)

Author keywords

Endo epicardial closure device; Epicardial closure device; Left atrial appendage; Stroke prevention

Indexed keywords

WARFARIN;

BLOOD CLOTTING; CARDIAC PATIENT; CATHETER ABLATION; CAUTERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY BLOOD VESSEL; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDIUM; EPICARDIUM; FALSE ANEURYSM; FIBEROSCOPE; FOLLOW UP; GUIDE WIRE; HEART ARRHYTHMIA; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MAGNET; OCCLUSION BALLOON CATHETER; PERICARDIAL EFFUSION; PERICARDITIS; PRIORITY JOURNAL; REVIEW; STERNOTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84897470770     PISSN: 22117458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccl.2014.01.003     Document Type: Review

References (26)

1. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
2. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
3. Lin H.J., Wolf P.A., Kelly-Hayes M., et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996, 27:1760-1764.
4. Whitlock R.P., Healey J.S., Connolly S.J. Left atrial appendage occlusion does not eliminate the need for warfarin. Circulation 2009, 120:1927-1932.
5. Sherman D.G. Stroke prevention in atrial fibrillation pharmacologic rate versus rhythm control. Stroke 2007, 38:615-617.
6. Stewart S., Hart C.L., Hole D.J., et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001, 86:516-521.
7. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007, 146:857-867.
8. Connolly S.J., Ezekowitz M.D., Yusuf S., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151.
9. Connolly S.J., Eikelboom J., Joyner C., et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011, 364:806-817.
10. Cleland J.G., Coletta A.P., Buga L., et al. Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT. Eur J Heart Fail 2011, 13:460-465.
11. Eikelboom J.W., Wallentin L., Connolly S.J., et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011, 123:2363-2372.
12. Hylek E.M., Evans-Molina C., Shea C., et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007, 115:2689-2696.
13. Bungard T.J., Ghali W.A., Teo K.K., et al. Why do patients with atrial fibrillation not receive warfarin?. Arch Intern Med 2000, 160:41-46.
14. Joshi D., Mazimba S., Neal Kay G., et al. Role of live/real time three-dimensional transesophageal echocardiography in the percutaneous epicardial closure of the left atrial appendage. Echocardiography 2012, 10.1111/j.1540-8175.2012.01821.x.
15. Bartus K., Han F.T., Bednarek J., et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 2013, 62(2):108-118.
16. Lee R.J., Bartus K., Yakubov S.J. Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model. Circ Cardiovasc Interv 2010, 3(3):224-229.
17. Singh S.M., Dukkipati S.R., d'Avila A., et al. Percutaneous left atrial appendage closure with an epicardial suture ligation approach: a prospective randomized pre-clinical feasibility study. Heart Rhythm 2010, 7(3):370-376.
18. Bartus K., Bednarek J., Myc J., et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm 2011, 8(2):188-193.
19. Massumi A., Chelu M.G., Nazeri A., et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol 2013, 111(6):869-873.
20. Di Biase L., Burkhardt J.D., Gibson D.N., et al. 2D and 3D TEE evaluation of an early reopening of the LARIAT epicardial left atrial appendage closure device. Heart Rhythm 2013, pii:S1547-5271(13)00898-9. 10.1016/j.hrthm.2013.08.023.
21. Della Bella P., Brugada J., Zeppenfeld K., et al. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol 2011, 4(5):653-659.
22. Koruth J.S., Aryana A., Dukkipati S.R., et al. Unusual complications of percutaneous epicardial access and epicardial mapping and ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol 2011, 4(6):882-888.
23. Keating V.P., Kolibash C.P., Khandheria B.K., et al. Left atrial laceration with epicardial ligation device. Ann Thorac Cardiovasc Surg 2013, [Epub ahead of print].
24. Lakkireddy D.R., Earnest M., Janga P., et al. Effect of endoepicardial percutaneous left atrial appendage ligation (Lariat) on arrhythmia burden in patients with atrial fibrillation. J Am Coll Cardiol 2013, 61(10):E385.
25. Friedman P.A., Asirvatham S.J., Dalegrave C., et al. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol 2009, 20:908-915.
26. Bruce C.J., Stanton C.M., Asirvatham S.J., et al. Percutaneous epicardial left atrial appendage closure: intermediate-term results. J Cardiovasc Electrophysiol 2011, 22:64-70.